Glioblastoma multiforme (GBM) is one of the most common and deadliest brain cancers . They are characterized as grade IV astrocytomas, arising from supportive cells in the nervous system known as astrocytes, and are most prevalent in the brain's cerebral hemispheres . Because of their rapid growth and invasion of surrounding brain tissue, these tumors are considered highly challenging to treat . Although they often don't metastasize to distant organs, GBM presents with symptoms associated with the neurological deterioration that affects the entire body system, from headaches and, seizures, nausea to altered senses and even cognitive and motor function loss . During treatment, GBM presents unique challenges due to factors such as tumor-induced seizures and an inherent resistance to conventional therapy . Standard treatment approaches generally involve a combination of surgery, radiation therapy, and chemotherapy, but as a result of the challenges above, the prognosis remains poor . In fact, the median survival time for a diagnosed patient is 15 months postdiagnosis (3).